TNFα and cytokines in rheumatoid arthritis physiopathology: Therapeutic prospect;Place du TNFα et des cytokines dans la physiopathologie de la polyarthrite rhumatoïde: Perspectives thérapeutiques

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 5, 2003, Pages 935-955

  Meyer, Olivier ^a   Paolaggi, Jean Baptiste ^b   Godeau, Pierre ^b   Bourel, Michel ^b   Adolphe, Monique ^b   Boulu, Roger ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

Arthritis reumatoid; Biological therapy; Cytokines; Synovial membrane; Tumor necrosis factor

Indexed keywords

CYTOKINE; GLYCOSAMINOGLYCAN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; ISOPROTEIN; METALLOPROTEINASE; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; AUTACOID; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BONE DESTRUCTION; BONE EROSION; CHONDROPATHY; CYTOKINE PRODUCTION; ENZYME RELEASE; IMMUNITY; MEDICAL PRACTICE; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SOLUBILITY; SYNOVIUM; SYNTHESIS; ANIMAL; ARTHRITIS; BIOLOGICAL MODEL; DBA MOUSE; DISEASE MODEL; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; TRANSGENIC MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; DRUG DESIGN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKINS; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; MODELS, BIOLOGICAL; RECEPTORS, TUMOR NECROSIS FACTOR; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242879089     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33977-9     Document Type: Article

References (41)

1. Fox D.A. - The role of T lymphocytes in rheumatoid arthritis. In "Rheumatoid Arthritis. New frontiers in pathogenesis and treatment" GS Firestein, GS Panayi, FA Wollheim ed. Oxford University Press, 2000, 89-100.
2. AREND W.P., GABAY C. - Cytokine networsk. In "Rheumatoid arthritis. New frontiers in pathogensis and treatment". GS Firestein, GS Panayi, FA Wollheim ed. Oxford University Press, 2000, 147-163.
3. AREND W.P. - Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Care & Res., 2001, 45, 101-106.
4. AREND W.P. - The innate immune system in rheumatoid arthritis. Arthritis Rheum., 2001, 44, 2224-2234.
5. BURMESTER G.R., STUHLMüLLER B., KEYSZER G., KINNE R.W. - Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis ? Arthritis Rheum., 1997, 40, 5-18.
6. FIRESTEIN G.S. - Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum., 1996, 39, 1781-1790.
7. ARDAVIN C., MARTINEZ DEL HOYO G., MARTIN P., ANJUÈRE F., ARIAS C.F., MARIN A.R. et al. - Trends Immunol., 2001, 22, 691-700.
8. FOX D.A. - The role of T cells in the immunopathogenesis of rheumatoid arthritis. New Perspectives. Arthritis Rheum., 1997, 40, 598-609.
9. MCINNES I.B., AL-MUGHALES J., FIELD M., LEUNG B.P., HUANG F.P., DIXON R. et al. - The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature med., 1996, 2, 175-182.
10. MCINNES I.B., GRACIE J.A., LIEW F.Y. - Interleukin-18, a novel cytokine in inflammatory rheumatic disease. Arthritis Rheum., 2001, 44, 1481-1483.
11. ALVARO-GRACIA J.M., ZVAIFLER N.J., BROWN C.B., KAUSHANSKY K., FIRESTEIN G.S. - Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-α. J Immunol., 1991, 146, 3365-3371.
12. WEBER A.J., DE BANDT M. - Angiogenesis, general mechanisms and implications for rheumatoid arthritis. Joint Bone Spine, 2000, 67, 366-383.
13. KANIK K.S., HAGIWARA E., YARBORO C.H., SCHUMACHER H.R., WILDER R.O., KLINMAN D.M. - Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J. Rheumatol., 1998, 25, 16-22.
14. GOLDRING S.R., GRAVALLESE E.M. - Pathogenesis of bone lesions in rheumatoid arthritis. Current Rheumatol. Reports, 2002, 4, 226-231.
15. FELDMANN M., MAINI R.N. - Anti-TNFα therapy of rheumatoid arthritis, what have we learned? Annual Rev. Immunol., 2001, 19, 163-196.
16. MEYER O. - Place des thérapeutiques anti-TNF dans la polyarthrite rhumatoïde. Presse méd., 2000, 29, 463-468.
17. KEFFER J., PROBERT L., CAZLARIS H., GEORGOPOULOS S., KASLARIS E., KIOUSSIS et al. - Transgenic mice expressing human tumor necrosis factor : a predictive genetic model of arthritis. EMBO Journal, 1991, 10, 4025-4031.
18. CAMPBELL I.K., O'DONNELL K., LAWLOR K.E, WICKS I.P. - Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J. Clin. Invest., 2001, 107, 1519-1527.
19. MUSSENER A., LITTON M.J., LINDROOS E., KLARESKOG L. - Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol., 1997, 107, 485-493.
20. WILLIAMS R.O., FELDMANN M., MAINI R.N. - Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci USA, 1992, 89, 9784-9788.
21. CHU C.Q., FIELD M., FELDMANN M., MAINI R.N. - Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum., 1991, 34, 1125-1132.
22. DELEURAN B.W., CHU C.Q., FIELD M., BRENNAN P.M., KATSIKIS P., FELDMANN M. et al. - Localisation of interleukin-1α, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage / panus junction in rheumatoid arthritis. Brit. J. Rheumatol., 1992, 31, 801-809.
23. AREND W.P., DAYER J.M. - Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum., 1995, 38, 151-160.
24. TAK P.P., SMEETS T.J., DAHA M.R., KLUIN P.M., MEIJERS K.A.E., BRAND R. et al. - Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum., 1997, 40, 217-225.
25. NISHIMOTO N., MAEDE K., KURITANI T., DEGUCHI H., SATO B., IMAI N. et al. - Safety and efficacy of repetitive treatment with humanized anti-interleukin-6 receptor antibody (MRA) in rheumatoid arthritis (abstract) Arthritis Rheum., 2001, 44, S84.
26. VERVOORDELDONK M.J.B., TAK P.T. - Cytokines in rheumatoid arthritis. Current Rheumatol Reports, 2002, 4, 208-217.
27. DINARELLO C.A., MOLDAWER L.L. - Proinflammatory and anti-inflammatory cytokines in rheumatoid arthritis. A primer for clinicians. Amgen Inc USA, third ed., 2002, 351.
28. KOTABE S., UDAGAWA N., TAKAHASHI N., MATSUZAKI K., ITOH K., ISHIYAMA S. et al. - IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest., 1999, 103, 1345-1352.
29. CHABAUD M., LUBBERTS E., JOOSTEN L., VAN DEN BERG W., MIOSSEC P. - IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res., 2001, 3, 168-177.
30. HOFBAUER L.C., HEUFELDER A.E. - The role of osteoprotegerin and receptor activator of nuclear factor κB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum., 2001, 44, 253-259.
31. PLATER-ZYBERK C., JOOSTEN L.A., HELSEN M.M., SATTONNET-ROCHE P., SIEGFRIED C., ALOUANI S. et al. - Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest., 2001, 12, 1825-1832.
32. VAN DEN BERG W.B. - Lessons from animal models of arthritis. Current Rheumatol Reports, 2002, 4, 231-239.
33. KATSIKIS P.D., CHU C.Q., BRENNAN F.M., MAINI R.N., FELDMANN M. - Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. exp. Med., 1994, 179, 1517-1527.
34. VAN ROON J.A.G., LAFEBER F.P.J.G., BIJLSMA J.W.J. - Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum., 2001, 44, 3-12.
35. CHABAUD M., MIOSSEC P. - The combination of tumor necrosis factor α blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum., 2001, 44, 1293-1303.
36. WENDLING D., RACADOT E., WIJDENES J. - Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J. Rheumatol., 1993, 20, 259-262.
37. LOUKINA G.V, SIGIDIN Y.A., SKURKOVICH B.S., SKURKOVICH S.S. - Double-blind placebo-controlled comparison of antibodies to tumor necrosis factor alpha (anti-TNF) and to interferon gamma (anti(IFNγ) therapy of rheumatoid arthritis (RA). Ann. Rheum. Dis., 2002, 61 suppl 1, abstract FRI0128, p. 197.
38. GRANT E.P., PICKARD M.D., BRISKIN M.J., GUTIERREZ-RAMOS J.C. - Gene expression profiles. Creating new perspectives in arthritis Research. Arthritis Rheum., 2002, 46, 874-884.
39. KEKOW J., KOCZAN D., DRYNDA S., DRYNDA A., PAP T., KÜHNE C. et al. - Monitoring of cytokine expression of patients with rheumatoid arthritis treated with anti-TNFα applying DNA-chip technology. Ann. Rheum. Dis., 2002, 61 suppl 1, abstract OP0082, p. 57.
40. LASSERRE M.N., FARMER K., PORTEK I., LEE C., SHNIER R., BIRD P. et al. - Synovial cytokine mRNA predicts joint damage in RA., A 2 year prospective study. Ann. Rheum. Dis., 2002, 61 suppl 1 abstract OP0081, p. 57.
41. KAVANAUGH A. - Combination cytokine therapy, the next generation of rheumatoid arthritis therapy? Arthritis Care & Res., 2002, 47, 87-92.